D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
PFE holding history
Pfizer Inc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PFE overviewAll 13F holders of PFEFull Q2 2026 holdings
- Shares (Q2 2026)
- 5,414,297
- Value
- $130.4M
- % of portfolio
- 0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 5,414,297 | $130.4M | 0.1% | −7,052,965−56.6% | Reduced | Holders |
| Q1 2026 | 12,467,262 | $350.1M | 0.3% | +9,051,769+265.0% | Added | Holders |
| Q4 2025 | 3,415,493 | $85.0M | 0.1% | −2,488,305−42.1% | Reduced | Holders |
| Q3 2025 | 5,903,798 | $150.4M | 0.1% | +2,154,868+57.5% | Added | Holders |
| Q2 2025 | 3,748,930 | $90.9M | 0.1% | −2,245,534−37.5% | Reduced | Holders |
| Q1 2025 | 5,994,464 | $151.9M | 0.2% | −1,712,316−22.2% | Reduced | Holders |
| Q4 2024 | 7,706,780 | $204.5M | 0.2% | +2,186,095+39.6% | Added | Holders |
| Q3 2024 | 5,520,685 | $159.8M | 0.2% | −2,904,036−34.5% | Reduced | Holders |
| Q2 2024 | 8,424,721 | $235.7M | 0.3% | −15,868,198−65.3% | Reduced | Holders |
| Q1 2024 | 24,292,919 | $674.1M | 0.9% | +9,770,933+67.3% | Added | Holders |
| Q4 2023 | 14,521,986 | $418.1M | 0.6% | +1,369,112+10.4% | Added | Holders |
| Q3 2023 | 13,152,874 | $436.3M | 0.7% | +6,675,541+103.1% | Added | Holders |
| Q2 2023 | 6,477,333 | $237.6M | 0.4% | −1,141,180−15.0% | Reduced | Holders |
| Q1 2023 | 7,618,513 | $310.8M | 0.5% | +361,509+5.0% | Added | Holders |
| Q4 2022 | 7,257,004 | $371.8M | 0.6% | +4,402,503+154.2% | Added | Holders |
| Q3 2022 | 2,854,501 | $124.9M | 0.2% | −27,604−1.0% | Reduced | Holders |
| Q2 2022 | 2,882,105 | $151.1M | 0.2% | −6,973,010−70.8% | Reduced | Holders |
| Q1 2022 | 9,855,115 | $510.2M | 0.7% | +6,533,107+196.7% | Added | Holders |
| Q4 2021 | 3,322,008 | $196.2M | 0.2% | −1,160,547−25.9% | Reduced | Holders |
| Q3 2021 | 4,482,555 | $192.8M | 0.2% | −1,541,261−25.6% | Reduced | Holders |
| Q2 2021 | 6,023,816 | $235.9M | 0.3% | +4,572,946+315.2% | Added | Holders |
| Q1 2021 | 1,450,870 | $52.6M | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.